Surgical management of placenta accreta: To leave or remove the placenta?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 121, Issue 2, 2014, Pages 163-170

  Perez Delboy, A ^a   Wright, J D ^a  

^a Division of Gynecologic Oncology ^*  (United States)

Author keywords

Caesarean hysterectomy; haemorrhage; hysterectomy; peripartum hysterectomy; placenta accreta

Indexed keywords

FRESH FROZEN PLASMA; METHOTREXATE;

ANESTHESIA; ARTIFICIAL EMBOLISM; CONSERVATIVE TREATMENT; ERYTHROCYTE TRANSFUSION; GYNECOLOGIC SURGERY; HUMAN; HYSTERECTOMY; HYSTEROTOMY; NEPHROTOXICITY; OBSTETRIC HEMORRHAGE; PANCYTOPENIA; PERIOPERATIVE PERIOD; PLACENTA ACCRETA; PRIORITY JOURNAL; REVIEW; SEPSIS; UTERINE ATONY; UTERUS BLEEDING;

EID: 84891366570     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12524     Document Type: Review

References (79)

1. Brace V, Kernaghan D, Penney G,. Learning from adverse clinical outcomes: major obstetric haemorrhage in Scotland, 2003-05. BJOG 2007; 114: 1388-96.
2. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B,. Deaths: final data for 2006. Natl Vital Stat Rep 2009; 57: 1-134.
3. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF,. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-74.
4. Wagaarachchi PT, Graham WJ, Penney GC, McCaw-Binns A, Yeboah Antwi K, Hall MH,. Holding up a mirror: changing obstetric practice through criterion-based clinical audit in developing countries. Int J Gynaecol Obstet 2001; 74: 119-30. discussion 31.
5. Weindling AM,. The confidential enquiry into maternal and child health (CEMACH). Arch Dis Child 2003; 88: 1034-7.
6. Eller AG, Porter TF, Soisson P, Silver RM,. Optimal management strategies for placenta accreta. BJOG 2009; 116: 648-54.
7. Hoffman MS, Karlnoski RA, Mangar D, Whiteman VE, Zweibel BR, Lockhart JL, et al. Morbidity associated with nonemergent hysterectomy for placenta accreta. Am J Obstet Gynecol 2010; 202: 628. e1-5.
8. Kastner ES, Figueroa R, Garry D, Maulik D,. Emergency peripartum hysterectomy: experience at a community teaching hospital. Obstet Gynecol 2002; 99: 971-5.
9. Knight M,. Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. BJOG 2007; 114: 1380-7.
10. Kwee A, Bots ML, Visser GH, Bruinse HW,. Emergency peripartum hysterectomy: a prospective study in The Netherlands. Eur J Obstet Gynecol Reprod Biol 2006; 124: 187-92.
11. Shellhaas CS, Gilbert S, Landon MB, Varner MW, Leveno KJ, Hauth JC, et al. The frequency and complication rates of hysterectomy accompanying cesarean delivery. Obstet Gynecol 2009; 114: 224-9.
12. Wright JD, Bonanno C, Shah M, Gaddipati S, Devine P,. Peripartum hysterectomy. Obstet Gynecol 2010; 116: 429-34.
13. Wright JD, Pri-Paz S, Herzog TJ, Shah M, Bonanno C, Lewin SN, et al. Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol 2011; 205: 38 e1-6.
14. Belfort MA,. Placenta accreta. Am J Obstet Gynecol 2010; 203: 430-9.
15. Eshkoli T, Weintraub AY, Sergienko R, Sheiner E,. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol 2013; 208: 219. e1-7.
16. Royal College of Obstetricians and Gynaecologists. Placenta praevia, placenta praevia accreta and vasa previa: diagnosis and management. Green-top Guideline No. 27. January 2011. [www.rcog.org.uk/files/rcog-corp/ GTG27PlacentaPraeviaJanuary2011.pdf]. Accessed 11 August 2013.
17. Wu S, Kocherginsky M, Hibbard JU,. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005; 192: 1458-61.
18. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107: 1226-32.
19. Miller DA, Chollet JA, Goodwin TM,. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997; 177: 210-4.
20. Clark SL, Koonings PP, Phelan JP,. Placenta previa/accreta and prior cesarean section. Obstet Gynecol 1985; 66: 89-92.
21. Henriet E, Roman H, Zanati J, Lebreton B, Sabourin JC, Loic M,. Pregnant noncommunicating rudimentary uterine horn with placenta percreta. JSLS 2008; 12: 101-3.
22. Usta IM, Hobeika EM, Musa AA, Gabriel GE, Nassar AH,. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol 2005; 193: 1045-9.
23. Wright JD, Herzog TJ, Shah M, Bonanno C, Lewin SN, Cleary K, et al. Regionalization of care for obstetric hemorrhage and its effect on maternal mortality. Obstet Gynecol 2010; 115: 1194-200.
24. Eller AG, Bennett MA, Sharshiner M, Masheter C, Soisson AP, Dodson M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 2011; 117: 331-7.
25. Matsubara S, Kuwata T, Usui R, Watanabe T, Izumi A, Ohkuchi A, et al. Important surgical measures and techniques at cesarean hysterectomy for placenta previa accreta. Acta Obstet Gynecol Scand 2013; 92: 372-7.
26. Lilker SJ, Meyer RA, Downey KN, Macarthur AJ,. Anesthetic considerations for placenta accreta. Int J Obstet Anesth 2011; 20: 288-92.
27. Langdana F, Geary M, Haw W, Keane D,. Peripartum hysterectomy in the 1990s: any new lessons? J Obstet Gynaecol 2001; 21: 121-3.
28. Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, Kelly TF, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol; 115: 65-9.
29. Robinson BK, Grobman WA,. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol 2010; 116: 835-42.
30. Alanis M, Hurst BS, Marshburn PB, Matthews ML,. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. Fertil Steril 2006; 86: 1514. e3-7.
31. Yu PC, Ou HY, Tsang LL, Kung FT, Hsu TY, Cheng YF,. Prophylactic intraoperative uterine artery embolization to control hemorrhage in abnormal placentation during late gestation. Fertil Steril 2009; 91: 1951-5.
32. La Folie T, Vidal V, Mehanna M, Capelle M, Jaquier A, Moulin G, et al. Results of endovascular treatment in cases of abnormal placentation with post-partum hemorrhage. J Obstet Gynaecol Res 2007; 33: 624-30.
33. Soyer P, Morel O, Fargeaudou Y, Sirol M, Staub F, Boudiaf M, et al. Value of pelvic embolization in the management of severe postpartum hemorrhage due to placenta accreta, increta or percreta. Eur J Radiol 2011; 80: 729-35.
34. Sivan E, Spira M, Achiron R, Rimon U, Golan G, Mazaki-Tovi S, et al. Prophylactic pelvic artery catheterization and embolization in women with placenta accreta: can it prevent cesarean hysterectomy? Am J Perinatol 2010; 27: 455-61.
35. Ojala K, Perala J, Kariniemi J, Ranta P, Raudaskoski T, Tekay A,. Arterial embolization and prophylactic catheterization for the treatment for severe obstetric hemorrhage. Acta Obstet Gynecol Scand 2005; 84: 1075-80.
36. Sewell MF, Rosenblum D, Ehrenberg H,. Arterial embolus during common iliac balloon catheterization at cesarean hysterectomy. Obstet Gynecol 2006; 108: 746-8.
37. Steinauer JE, Diedrich JT, Wilson MW, Darney PD, Vargas JE, Drey EA,. Uterine artery embolization in postabortion hemorrhage. Obstet Gynecol 2008; 111: 881-9.
38. Uchiyama D, Koganemaru M, Abe T, Hori D, Hayabuchi N,. Arterial catheterization and embolization for management of emergent or anticipated massive obstetrical hemorrhage. Radiat Med 2008; 26: 188-97.
39. Shrivastava V, Nageotte M, Major C, Haydon M, Wing D,. Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta. Am J Obstet Gynecol 2007; 197: 402. e1-5.
40. Levine AB, Kuhlman K, Bonn J,. Placenta accreta: comparison of cases managed with and without pelvic artery balloon catheters. J Matern Fetal Med 1999; 8: 173-6.
41. Bodner LJ, Nosher JL, Gribbin C, Siegel RL, Beale S, Scorza W,. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol 2006; 29: 354-61.
42. Tan CH, Tay KH, Sheah K, Kwek K, Wong K, Tan HK, et al. Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. AJR Am J Roentgenol 2007; 189: 1158-63.
43. Shih JC, Liu KL, Shyu MK,. Temporary balloon occlusion of the common iliac artery: new approach to bleeding control during cesarean hysterectomy for placenta percreta. Am J Obstet Gynecol 2005; 193: 1756-8.
44. Kidney DD, Nguyen AM, Ahdoot D, Bickmore D, Deutsch LS, Majors C,. Prophylactic perioperative hypogastric artery balloon occlusion in abnormal placentation. AJR Am J Roentgenol 2001; 176: 1521-4.
45. Stotler B, Padmanabhan A, Devine P, Wright J, Spitalnik SL, Schwartz J,. Transfusion requirements in obstetric patients with placenta accreta. Transfusion 2011; 51: 2627-33.
46. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008; 248: 447-58.
47. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63: 805-13.
48. Gunter OL Jr, Au BK, Isbell JM, Mowery NT, Young PP, Cotton BA,. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma 2008; 65: 527-34.
49. Holcomb JB, Zarzabal LA, Michalek JE, Kozar RA, Spinella PC, Perkins JG, et al. Increased platelet:RBC ratios are associated with improved survival after massive transfusion. J Trauma 2011; 71 (2 Suppl 3): S318-28.
50. Brown LM, Aro SO, Cohen MJ, Holcomb JB, Wade CE, Brasel KJ, et al. A high fresh frozen plasma: packed red blood cell transfusion ratio decreases mortality in all massively transfused trauma patients regardless of admission international normalized ratio. J Trauma 2011; 71 (2 Suppl 3): S358-63.
51. Rowell SE, Barbosa RR, Diggs BS, Schreiber MA, Holcomb JB, Wade CE, et al. Effect of high product ratio massive transfusion on mortality in blunt and penetrating trauma patients. J Trauma 2011; 71 (2 Suppl 3): S353-7.
52. Pasquier P, Gayat E, Rackelboom T, La Rosa J, Tashkandi A, Tesniere A, et al. An observational study of the fresh frozen plasma: red blood cell ratio in postpartum hemorrhage. Anesth Analg 2013; 116: 155-61.
53. Sullivan I, Faulds J, Ralph C,. Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective caesarean section. Br J Anaesth 2008; 101: 225-9.
54. Catling S, Joels L,. Cell salvage in obstetrics: the time has come. BJOG 2005; 112: 131-2.
55. Waters JH, Biscotti C, Potter PS, Phillipson E,. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology 2000; 92: 1531-6.
56. Allam J, Cox M, Yentis SM,. Cell salvage in obstetrics. Int J Obstet Anesth 2008; 17: 37-45.
57. Catling S,. Blood conservation techniques in obstetrics: a UK perspective. Int J Obstet Anesth 2007; 16: 241-9.
58. Hong YM, Loughlin KR,. The use of hemostatic agents and sealants in urology. J Urol 2006; 176: 2367-74.
59. Pursifull NF, Morey AF,. Tissue glues and nonsuturing techniques. Curr Opin Urol 2007; 17: 396-401.
60. Rousou J, Levitsky S, Gonzalez-Lavin L, Cosgrove D, Magilligan D, Weldon C, et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg 1989; 97: 194-203.
61. Oz MC, Cosgrove DM 3rd, Badduke BR, Hill JD, Flannery MR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg 2000; 69: 1376-82.
62. Carless PA, Anthony DM, Henry DA,. Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion. Br J Surg 2002; 89: 695-703.
63. Welsh A, McLintock C, Gatt S, Somerset D, Popham P, Ogle R,. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2008; 48: 12-6.
64. Franchini M, Franchi M, Bergamini V, Salvagno GL, Montagnana M, Lippi G,. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage. Semin Thromb Hemost 2008; 34: 104-12.
65. Bouma LS, Bolte AC, van Geijn HP,. Use of recombinant activated factor VII in massive postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2008; 137: 172-7.
66. Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, et al. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. Obstet Gynecol 2007; 110: 1270-8.
67. Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, et al. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg 2009; 109: 1908-15.
68. Wissa I, Ebeid E, El-Shawarby S, Chandakas S, Kamal T, Hill N,. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience. J Obstet Gynaecol 2009; 29: 21-4.
69. Awan N, Bennett MJ, Walters WA,. Emergency peripartum hysterectomy: a 10-year review at the Royal Hospital for Women, Sydney. Aust N Z J Obstet Gynaecol 2011; 51: 210-5.
70. Whiteman MK, Kuklina E, Hillis SD, Jamieson DJ, Meikle SF, Posner SF, et al. Incidence and determinants of peripartum hysterectomy. Obstet Gynecol 2006; 108: 1486-92.
71. Yucel O, Ozdemir I, Yucel N, Somunkiran A,. Emergency peripartum hysterectomy: a 9-year review. Arch Gynecol Obstet 2006; 274: 84-7.
72. Wright JD, Devine P, Shah M, Gaddipati S, Lewin SN, Simpson LL, et al. Morbidity and mortality of peripartum hysterectomy. Obstet Gynecol 2010; 115: 1187-93.
73. Wright JD, Pri-Paz S, Herzog TJ, Shah M, Bonanno C, Lewin SN, et al. Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol 2011; 205: 38. e1-6.
74. Chandraharan E, Rao S, Belli AM, Arulkumaran S,. The Triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet 2012; 117: 191-4.
75. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S,. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv 2007; 62: 540-7.
76. Matsumura N, Inoue T, Fukuoka M, Sagawa N, Fujii S,. Changes in the serum levels of human chorionic gonadotropin and the pulsatility index of uterine arteries during conservative management of retained adherent placenta. J Obstet Gynaecol Res 2000; 26: 81-7.
77. Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010; 115: 526-34.
78. Steins Bisschop CN, Schaap TP, Vogelvang TE, Scholten PC,. Invasive placentation and uterus preserving treatment modalities: a systematic review. Arch Gynecol Obstet 2011; 284: 491-502.
79. Timmermans S, van Hof AC, Duvekot JJ,. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv 2007; 62: 529-39.